Cendakimab fell short of the bar. The antibody hits IL-13, one of the interleukins targeted by Regeneron and Sanofi’s ...

Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era ...

Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...

Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...

Regeneron reported Q4 2024 earnings today and declared its first-ever dividend of $0.88 per quarter. Click here to know what ...

Despite lackluster sales of Eylea’s high-dose formulation and Sanofi-partnered Dupixent, Regeneron beat Q4 forecasts overall ...

The Boston icons, Affleck, Brady and Damon, formed a boy band and performed for Lopez in Dunkin's 2024 Super Bowl commercial Sabrina Weiss is the Editorial Assistant of PEOPLE's food department.

Executives try to figure out what went right and appealed the most and apply those lessons to the next commercial. “This is a huge priority for us every year,” he says.

Budweiser unveiled its new 98-second commercial ad on Monday for the upcoming Super Bowl LIX called "First Delivery." It will feature a new young star — a Clydesdale foal that was born at its ...

The agreement provides Orion with commercial licenses for up to two bispecific antibodies. “Partnering with Invenra represents an important step in Orion’s strategy to expand our portfolio in the ...

Head of Investor Relations Welcome to the Q4 and full year 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide 3. Here we have the ...

One primary reason is the strong performance and potential of Dupixent, which is expected to partially counterbalance the uncertainties surrounding Eylea. The expected growth in Dupixent’s ...